| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.38 | 0.002 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.004 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |